Trial · NCT00056810
Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
NCT00056810, Phase 2, Completed, FDA Office of Orphan Products Development
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine. Trials, record NCT00056810. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00056810
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
- NCT number
- NCT00056810
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 30 participants
- Lead sponsor
- FDA Office of Orphan Products Development
- Conditions
- Guillain-Barre Syndrome
- Interventions
- 4-aminopyridine (4-AP)
- First posted
- 2003-03-25
- Last updated
- 2015-03-25
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | American Spinal Injury Association (ASIA) Motor Score at 8 weeks and 19 weeks | ||
| Primary | Functional Independence Measure (FIM) Motor scale at 8 weeks and 19 weeks | ||
| Secondary | The following are all at 8 weeks and 19 weeks: Hand Dynamometer | ||
| Secondary | Visual Analog Pain Scale | ||
| Secondary | McGill Pain Questionnaire-Short Form | ||
| Secondary | Neuromuscular Functional Assessment Index | ||
| Secondary | Jebsen-Taylor Hand Function Test | ||
| Secondary | Minnesota Rate of Manipulation and Manual Dexterity Tests | ||
| Secondary | The Get Up and Go Test | ||
| Secondary | 6-Minute Walk Test |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00056810
GET https://conductscience.org/api/trials/v1/NCT00056810/registered